Study of Thymosin Beta 4 in Patients With Pressure Ulcers

Clinical trial NCT00382174 · COMPLETED

Trial details

NCT number: NCT00382174
Sponsor: RegeneRx Biopharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pressure Ulcers

Start date: 2006-05-01
Primary completion: 2008-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.